[96a5a0]: / output / allTrials / identified / NCT00860860_identified.json

Download this file

540 lines (540 with data), 22.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
{
"info": {
"nct_id": "NCT00860860",
"official_title": "Phase I Clinical Study of the Feasibility of Pretargeted Radioimmunotherapy of an Anti-CEA Bispecific Antibody and Lu-177-labeled Peptide in Patients With Advanced Colorectal Cancer",
"inclusion_criteria": "* Patients with CEA expressing advanced colorectal tumors for which no standard treatment is available\n* WHO performance status: 0 or 1\n* Having normal hematological function: Neutrophils > 1.5 x 109/l; Platelet count > 150 x 109/l, without transfusion during the previous month; Hemoglobin > 5.6 mmol/l\n* Total bilirubin < 2 x upper limit of normal (ULN)\n* ASAT, ALAT < 3 x ULN\n* Serum creatinine < 2 x ULN\n* Cockcroft clearance > 50 ml/min\n* Negative pregnancy test for women of child¬bearing potential (urine or serum)\n* Age over 18 years\n* Ability to provide written informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Known metastases to the brain\n* Chemotherapy, external beam radiation or immunotherapy within 4 weeks prior to study. Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.\n* Prior angiogenesis inhibitors within 4 weeks; bevacizumab within 8 weeks\n* Cardiac disease with New York Heart Association classification of III or IV\n* Patients who are pregnant, nursing or of reproductive potential and are not practicing an effective method of contraception\n* Any unrelated illness, e.g. active infection, inflammation, medical condition or laboratory abnormalities, which in the judgement of the investigator will significantly affect patients' clinical status\n* Life expectancy shorter than 6 months.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with CEA expressing advanced colorectal tumors for which no standard treatment is available",
"criterions": [
{
"exact_snippets": "CEA expressing advanced colorectal tumors",
"criterion": "CEA expression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "advanced colorectal tumors",
"criterion": "advanced colorectal tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "no standard treatment is available",
"criterion": "standard treatment availability",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* WHO performance status: 0 or 1",
"criterions": [
{
"exact_snippets": "WHO performance status: 0 or 1",
"criterion": "WHO performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Having normal hematological function: Neutrophils > 1.5 x 109/l; Platelet count > 150 x 109/l, without transfusion during the previous month; Hemoglobin > 5.6 mmol/l",
"criterions": [
{
"exact_snippets": "Neutrophils > 1.5 x 109/l",
"criterion": "neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "x 10^9/l"
}
}
]
},
{
"exact_snippets": "Platelet count > 150 x 109/l, without transfusion during the previous month",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 150,
"unit": "x 10^9/l"
}
},
{
"requirement_type": "transfusion",
"expected_value": false
}
]
},
{
"exact_snippets": "Hemoglobin > 5.6 mmol/l",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 5.6,
"unit": "mmol/l"
}
}
]
}
]
},
{
"line": "* Total bilirubin < 2 x upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Total bilirubin < 2 x upper limit of normal (ULN)",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* ASAT, ALAT < 3 x ULN",
"criterions": [
{
"exact_snippets": "ASAT, ALAT < 3 x ULN",
"criterion": "ASAT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "ASAT, ALAT < 3 x ULN",
"criterion": "ALAT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Serum creatinine < 2 x ULN",
"criterions": [
{
"exact_snippets": "Serum creatinine < 2 x ULN",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Cockcroft clearance > 50 ml/min",
"criterions": [
{
"exact_snippets": "Cockcroft clearance > 50 ml/min",
"criterion": "Cockcroft clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "ml/min"
}
}
]
}
]
},
{
"line": "* Negative pregnancy test for women of child¬bearing potential (urine or serum)",
"criterions": [
{
"exact_snippets": "Negative pregnancy test for women of child¬bearing potential (urine or serum)",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Age over 18 years",
"criterions": [
{
"exact_snippets": "Age over 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Ability to provide written informed consent",
"criterions": [
{
"exact_snippets": "Ability to provide written informed consent",
"criterion": "written informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Known metastases to the brain",
"criterions": [
{
"exact_snippets": "Known metastases to the brain",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Chemotherapy, external beam radiation or immunotherapy within 4 weeks prior to study. Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.",
"criterions": [
{
"exact_snippets": "Chemotherapy ... within 4 weeks prior to study.",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "external beam radiation ... within 4 weeks prior to study.",
"criterion": "external beam radiation",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "immunotherapy within 4 weeks prior to study.",
"criterion": "immunotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.",
"criterion": "limited field external beam radiotherapy",
"requirements": [
{
"requirement_type": "purpose",
"expected_value": "prevent pathological fractures"
},
{
"requirement_type": "condition",
"expected_value": "unirradiated, evaluable lesions elsewhere are present"
}
]
}
]
},
{
"line": "* Prior angiogenesis inhibitors within 4 weeks; bevacizumab within 8 weeks",
"criterions": [
{
"exact_snippets": "Prior angiogenesis inhibitors within 4 weeks",
"criterion": "prior angiogenesis inhibitors",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "bevacizumab within 8 weeks",
"criterion": "prior bevacizumab",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"operator": "<=",
"value": 8,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Cardiac disease with New York Heart Association classification of III or IV",
"criterions": [
{
"exact_snippets": "Cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "New York Heart Association classification of III or IV",
"criterion": "New York Heart Association classification",
"requirements": [
{
"requirement_type": "classification",
"expected_value": [
"III",
"IV"
]
}
]
}
]
},
{
"line": "* Patients who are pregnant, nursing or of reproductive potential and are not practicing an effective method of contraception",
"criterions": [
{
"exact_snippets": "Patients who are pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "of reproductive potential",
"criterion": "reproductive potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "not practicing an effective method of contraception",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "practice",
"expected_value": true
}
]
}
]
},
{
"line": "* Any unrelated illness, e.g. active infection, inflammation, medical condition or laboratory abnormalities, which in the judgement of the investigator will significantly affect patients' clinical status",
"criterions": [
{
"exact_snippets": "active infection",
"criterion": "active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "inflammation",
"criterion": "inflammation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "medical condition",
"criterion": "medical condition",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "laboratory abnormalities",
"criterion": "laboratory abnormalities",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Life expectancy shorter than 6 months.",
"criterions": [
{
"exact_snippets": "Life expectancy shorter than 6 months.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}